群(周期表)
表型
医学
遗传学
内科学
生物
化学
基因
有机化学
作者
M. Sree Bhagavathi,Nandini Das,Satya Prakash,Ansuman Sahu,Suman Sudha Routray,Somnath Mukherjee
出处
期刊:Immunohematology / American Red Cross
[Exeley Inc]
日期:2021-01-01
卷期号:37 (4): 160-164
被引量:4
标识
DOI:10.21307/immunohematology-2021-026
摘要
Abstract Individuals with the rare para-Bombay phenotype have inherited defects in producing H associated with FUT1 and/or FUT2 genes. We report a case of blood group discrepancy in a para-Bombay patient from a tertiary care hospital of eastern India. A 31-year-old woman with rheumatic heart disease presented with fatigue and breathlessness and was then scheduled for valvuloplasty, for which a blood transfusion request was sent to the blood center. During pre-transfusion testing, red blood cell (RBC) testing showed group O, and serum testing showed strong reactivity with group B RBCs, weak reactivity with group O RBCs, and very weak reactivity with group A RBCs. Saliva inhibition testing and enzyme treatment of RBCs concluded the patient to be of “A h para-Bombay” phenotype. The patient’s Lewis phenotype was Le(a–b+). This patient’s serum also had cold-reacting anti-IH along with anti-B. This case report highlights the importance of performing an advanced immunohematologic workup, including adsorption, elution, enzyme treatment, and saliva inhibition testing for identification of weak A or B subgroups as well as the rare para-Bombay blood group, when routine ABO typing, using forward and reverse grouping, is inconclusive. Accurate identification of blood group helps in preventing transfusion-related adverse events and encouraging safe transfusion practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI